Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC35426106501;106502;106503 chr2:178530339;178530338;178530337chr2:179395066;179395065;179395064
N2AB33785101578;101579;101580 chr2:178530339;178530338;178530337chr2:179395066;179395065;179395064
N2A3285898797;98798;98799 chr2:178530339;178530338;178530337chr2:179395066;179395065;179395064
N2B2636179306;79307;79308 chr2:178530339;178530338;178530337chr2:179395066;179395065;179395064
Novex-12648679681;79682;79683 chr2:178530339;178530338;178530337chr2:179395066;179395065;179395064
Novex-22655379882;79883;79884 chr2:178530339;178530338;178530337chr2:179395066;179395065;179395064
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: TTG
  • RefSeq wild type template codon: AAC
  • Domain: Ig-166
  • Domain position: 7
  • Structural Position: 8
  • Q(SASA): 0.0986
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/S None None 0.999 N 0.846 0.333 0.782707291019 gnomAD-4.0.0 1.59095E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85757E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.8116 likely_pathogenic 0.8092 pathogenic -1.881 Destabilizing 0.998 D 0.649 neutral None None None None N
L/C 0.9035 likely_pathogenic 0.8913 pathogenic -1.496 Destabilizing 1.0 D 0.801 deleterious None None None None N
L/D 0.9899 likely_pathogenic 0.9889 pathogenic -1.052 Destabilizing 0.999 D 0.903 deleterious None None None None N
L/E 0.9471 likely_pathogenic 0.9463 pathogenic -0.997 Destabilizing 0.999 D 0.888 deleterious None None None None N
L/F 0.4159 ambiguous 0.4127 ambiguous -1.35 Destabilizing 0.999 D 0.719 prob.delet. N 0.46537026 None None N
L/G 0.9392 likely_pathogenic 0.9355 pathogenic -2.253 Highly Destabilizing 0.999 D 0.889 deleterious None None None None N
L/H 0.8952 likely_pathogenic 0.8916 pathogenic -1.461 Destabilizing 1.0 D 0.9 deleterious None None None None N
L/I 0.1961 likely_benign 0.1994 benign -0.905 Destabilizing 0.998 D 0.561 neutral None None None None N
L/K 0.9113 likely_pathogenic 0.913 pathogenic -1.109 Destabilizing 0.999 D 0.862 deleterious None None None None N
L/M 0.269 likely_benign 0.2705 benign -0.911 Destabilizing 0.999 D 0.743 deleterious N 0.459369553 None None N
L/N 0.9357 likely_pathogenic 0.9308 pathogenic -1.023 Destabilizing 0.999 D 0.904 deleterious None None None None N
L/P 0.8196 likely_pathogenic 0.7898 pathogenic -1.201 Destabilizing 0.999 D 0.9 deleterious None None None None N
L/Q 0.8215 likely_pathogenic 0.8189 pathogenic -1.142 Destabilizing 0.999 D 0.885 deleterious None None None None N
L/R 0.8718 likely_pathogenic 0.8724 pathogenic -0.657 Destabilizing 0.999 D 0.874 deleterious None None None None N
L/S 0.9038 likely_pathogenic 0.898 pathogenic -1.791 Destabilizing 0.999 D 0.846 deleterious N 0.468915433 None None N
L/T 0.8083 likely_pathogenic 0.8061 pathogenic -1.603 Destabilizing 0.999 D 0.765 deleterious None None None None N
L/V 0.3127 likely_benign 0.3176 benign -1.201 Destabilizing 0.997 D 0.545 neutral N 0.464863281 None None N
L/W 0.8148 likely_pathogenic 0.8201 pathogenic -1.393 Destabilizing 1.0 D 0.848 deleterious N 0.506137901 None None N
L/Y 0.9058 likely_pathogenic 0.91 pathogenic -1.14 Destabilizing 0.999 D 0.84 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.